APR Applied Pharma Research announces a 50mg diclofenac potassium sachet for drinkable solution, developed according to its new patented drug delivery technology useful to improve efficacy and safety of fast acting formulations containing diclofenac More
CCL Pharmaceuticals, the independent specialist contract aerosol developer and manufacturer, completes respiratory mdi development projects for two major European clients More
The German R&D Company Labtec GmbH and the Swiss R&D Company APR Applied Pharma Research S.A. have recently partnered together for the further development, registration and licensing out of a high tech., top of the art NSAID topical patch for More